Global Personalized Cell Therapeutic Market Growth 2025-2031

Publication ID:

LPI04255210

Publication Date:

April 23, 2025

Pages:

133

Publisher:

LPI

Countries:

Global [1]

USD 3,660.00

Pharmaceutical Manufacturing [2]

Healthcare [3]

Pharma & Healthcare [4]

Description:

The global Personalized Cell Therapeutic market size is predicted to grow from US$ 16490 million in 2025 to US$ 31530 million in 2031; it is expected to grow at a CAGR of 11.4% from 2025 to 2031.
Personalized cells are undifferentiated stem cells that can be divided to generate offspring cells designated as specialized or personalized stem cells. Specialized treatment of numerous chronic diseases such as autoimmune and cancer through vaccinating living cells into the body of patients to boost the personalized cell therapy market. As there are multiple types of living cells such as immature and mature living cell, blood and bone marrow cell and embryonic stem cells that are mainly utilized in personalized cell therapy.
Several manufacturers are conducting numerous clinical trials to develop new personalized cell therapies for chronic diseases such as cancer, diabetes and other autoimmune diseases. For example, in April 2019, Orgenesis Inc. received approval from the Institutional Review Board (IRB) to collect liver biopsy samples from patients at the Rambam Medical Center in Israel. Samples were collected to confirm the safety and efficacy of hepatocytes for individualized cell replacement therapy in patients with insulin-dependent diabetes mellitus following total or partial pancreatectomy. Hence, increasing number of studies is expected to boost the growth of the global personalized cell therapy market.
The 鈥淧ersonalized Cell Therapeutic Industry Forecast鈥� looks at past sales and reviews total world Personalized Cell Therapeutic sales in 2024, providing a comprehensive analysis by region and market sector of projected Personalized Cell Therapeutic sales for 2025 through 2031. With Personalized Cell Therapeutic sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Personalized Cell Therapeutic industry.
This Insight Report provides a comprehensive analysis of the global Personalized Cell Therapeutic landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Personalized Cell Therapeutic portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms鈥� unique position in an accelerating global Personalized Cell Therapeutic market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Personalized Cell Therapeutic and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Personalized Cell Therapeutic.
This report presents a comprehensive overview, market shares, and growth opportunities of Personalized Cell Therapeutic market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
Embryonic Stem Cells
Adult Stem Cell
Induced Pluripotent Cells
Other
Segmentation by Application:
Cardiovascular Diseases
Neurological Disorders
Diabetes
Oncology
Other
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
AbbVie Inc
Bausch Health Companies Inc
Teva Pharmaceutical Industries Ltd
Cipla
Lupin
Sun Pharmaceuticals Industries Ltd
Hikma Pharmaceuticals PLC
AstraZeneca
GSK Plc
Pfizer Inc
Amneal Pharmaceuticals LLC
Alvogen
F. Hoffmann-La Roche Ltd
Amgen Inc
Jazz Pharmaceuticals, Inc
Amicus Therapeutics, Inc
MeiraGTx Limited
Rocket Pharmaceuticals, Inc
Gilead Sciences, Inc
Key Questions Addressed in this Report
What is the 10-year outlook for the global Personalized Cell Therapeutic market?
What factors are driving Personalized Cell Therapeutic market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Personalized Cell Therapeutic market opportunities vary by end market size?
How does Personalized Cell Therapeutic break out by Type, by Application?

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Personalized Cell Therapeutic Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for Personalized Cell Therapeutic by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for Personalized Cell Therapeutic by Country/Region, 2020, 2024 & 2031
2.2 Personalized Cell Therapeutic Segment by Type
2.2.1 Embryonic Stem Cells
2.2.2 Adult Stem Cell
2.2.3 Induced Pluripotent Cells
2.2.4 Other
2.3 Personalized Cell Therapeutic Sales by Type
2.3.1 Global Personalized Cell Therapeutic Sales Market Share by Type (2020-2025)
2.3.2 Global Personalized Cell Therapeutic Revenue and Market Share by Type (2020-2025)
2.3.3 Global Personalized Cell Therapeutic Sale Price by Type (2020-2025)
2.4 Personalized Cell Therapeutic Segment by Application
2.4.1 Cardiovascular Diseases
2.4.2 Neurological Disorders
2.4.3 Diabetes
2.4.4 Oncology
2.4.5 Other
2.5 Personalized Cell Therapeutic Sales by Application
2.5.1 Global Personalized Cell Therapeutic Sale Market Share by Application (2020-2025)
2.5.2 Global Personalized Cell Therapeutic Revenue and Market Share by Application (2020-2025)
2.5.3 Global Personalized Cell Therapeutic Sale Price by Application (2020-2025)
3 Global by Company
3.1 Global Personalized Cell Therapeutic Breakdown Data by Company
3.1.1 Global Personalized Cell Therapeutic Annual Sales by Company (2020-2025)
3.1.2 Global Personalized Cell Therapeutic Sales Market Share by Company (2020-2025)
3.2 Global Personalized Cell Therapeutic Annual Revenue by Company (2020-2025)
3.2.1 Global Personalized Cell Therapeutic Revenue by Company (2020-2025)
3.2.2 Global Personalized Cell Therapeutic Revenue Market Share by Company (2020-2025)
3.3 Global Personalized Cell Therapeutic Sale Price by Company
3.4 Key Manufacturers Personalized Cell Therapeutic Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Personalized Cell Therapeutic Product Location Distribution
3.4.2 Players Personalized Cell Therapeutic Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 World Historic Review for Personalized Cell Therapeutic by Geographic Region
4.1 World Historic Personalized Cell Therapeutic Market Size by Geographic Region (2020-2025)
4.1.1 Global Personalized Cell Therapeutic Annual Sales by Geographic Region (2020-2025)
4.1.2 Global Personalized Cell Therapeutic Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Personalized Cell Therapeutic Market Size by Country/Region (2020-2025)
4.2.1 Global Personalized Cell Therapeutic Annual Sales by Country/Region (2020-2025)
4.2.2 Global Personalized Cell Therapeutic Annual Revenue by Country/Region (2020-2025)
4.3 Americas Personalized Cell Therapeutic Sales Growth
4.4 APAC Personalized Cell Therapeutic Sales Growth
4.5 Europe Personalized Cell Therapeutic Sales Growth
4.6 Middle East & Africa Personalized Cell Therapeutic Sales Growth
5 Americas
5.1 Americas Personalized Cell Therapeutic Sales by Country
5.1.1 Americas Personalized Cell Therapeutic Sales by Country (2020-2025)
5.1.2 Americas Personalized Cell Therapeutic Revenue by Country (2020-2025)
5.2 Americas Personalized Cell Therapeutic Sales by Type (2020-2025)
5.3 Americas Personalized Cell Therapeutic Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Personalized Cell Therapeutic Sales by Region
6.1.1 APAC Personalized Cell Therapeutic Sales by Region (2020-2025)
6.1.2 APAC Personalized Cell Therapeutic Revenue by Region (2020-2025)
6.2 APAC Personalized Cell Therapeutic Sales by Type (2020-2025)
6.3 APAC Personalized Cell Therapeutic Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Personalized Cell Therapeutic by Country
7.1.1 Europe Personalized Cell Therapeutic Sales by Country (2020-2025)
7.1.2 Europe Personalized Cell Therapeutic Revenue by Country (2020-2025)
7.2 Europe Personalized Cell Therapeutic Sales by Type (2020-2025)
7.3 Europe Personalized Cell Therapeutic Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Personalized Cell Therapeutic by Country
8.1.1 Middle East & Africa Personalized Cell Therapeutic Sales by Country (2020-2025)
8.1.2 Middle East & Africa Personalized Cell Therapeutic Revenue by Country (2020-2025)
8.2 Middle East & Africa Personalized Cell Therapeutic Sales by Type (2020-2025)
8.3 Middle East & Africa Personalized Cell Therapeutic Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Personalized Cell Therapeutic
10.3 Manufacturing Process Analysis of Personalized Cell Therapeutic
10.4 Industry Chain Structure of Personalized Cell Therapeutic
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Personalized Cell Therapeutic Distributors
11.3 Personalized Cell Therapeutic Customer
12 World Forecast Review for Personalized Cell Therapeutic by Geographic Region
12.1 Global Personalized Cell Therapeutic Market Size Forecast by Region
12.1.1 Global Personalized Cell Therapeutic Forecast by Region (2026-2031)
12.1.2 Global Personalized Cell Therapeutic Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Personalized Cell Therapeutic Forecast by Type (2026-2031)
12.7 Global Personalized Cell Therapeutic Forecast by Application (2026-2031)
13 Key Players Analysis
13.1 AbbVie Inc
13.1.1 AbbVie Inc Company Information
13.1.2 AbbVie Inc Personalized Cell Therapeutic Product Portfolios and Specifications
13.1.3 AbbVie Inc Personalized Cell Therapeutic Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 AbbVie Inc Main Business Overview
13.1.5 AbbVie Inc Latest Developments
13.2 Bausch Health Companies Inc
13.2.1 Bausch Health Companies Inc Company Information
13.2.2 Bausch Health Companies Inc Personalized Cell Therapeutic Product Portfolios and Specifications
13.2.3 Bausch Health Companies Inc Personalized Cell Therapeutic Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 Bausch Health Companies Inc Main Business Overview
13.2.5 Bausch Health Companies Inc Latest Developments
13.3 Teva Pharmaceutical Industries Ltd
13.3.1 Teva Pharmaceutical Industries Ltd Company Information
13.3.2 Teva Pharmaceutical Industries Ltd Personalized Cell Therapeutic Product Portfolios and Specifications
13.3.3 Teva Pharmaceutical Industries Ltd Personalized Cell Therapeutic Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 Teva Pharmaceutical Industries Ltd Main Business Overview
13.3.5 Teva Pharmaceutical Industries Ltd Latest Developments
13.4 Cipla
13.4.1 Cipla Company Information
13.4.2 Cipla Personalized Cell Therapeutic Product Portfolios and Specifications
13.4.3 Cipla Personalized Cell Therapeutic Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 Cipla Main Business Overview
13.4.5 Cipla Latest Developments
13.5 Lupin
13.5.1 Lupin Company Information
13.5.2 Lupin Personalized Cell Therapeutic Product Portfolios and Specifications
13.5.3 Lupin Personalized Cell Therapeutic Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 Lupin Main Business Overview
13.5.5 Lupin Latest Developments
13.6 Sun Pharmaceuticals Industries Ltd
13.6.1 Sun Pharmaceuticals Industries Ltd Company Information
13.6.2 Sun Pharmaceuticals Industries Ltd Personalized Cell Therapeutic Product Portfolios and Specifications
13.6.3 Sun Pharmaceuticals Industries Ltd Personalized Cell Therapeutic Sales, Revenue, Price and Gross Margin (2020-2025)
13.6.4 Sun Pharmaceuticals Industries Ltd Main Business Overview
13.6.5 Sun Pharmaceuticals Industries Ltd Latest Developments
13.7 Hikma Pharmaceuticals PLC
13.7.1 Hikma Pharmaceuticals PLC Company Information
13.7.2 Hikma Pharmaceuticals PLC Personalized Cell Therapeutic Product Portfolios and Specifications
13.7.3 Hikma Pharmaceuticals PLC Personalized Cell Therapeutic Sales, Revenue, Price and Gross Margin (2020-2025)
13.7.4 Hikma Pharmaceuticals PLC Main Business Overview
13.7.5 Hikma Pharmaceuticals PLC Latest Developments
13.8 AstraZeneca
13.8.1 AstraZeneca Company Information
13.8.2 AstraZeneca Personalized Cell Therapeutic Product Portfolios and Specifications
13.8.3 AstraZeneca Personalized Cell Therapeutic Sales, Revenue, Price and Gross Margin (2020-2025)
13.8.4 AstraZeneca Main Business Overview
13.8.5 AstraZeneca Latest Developments
13.9 GSK Plc
13.9.1 GSK Plc Company Information
13.9.2 GSK Plc Personalized Cell Therapeutic Product Portfolios and Specifications
13.9.3 GSK Plc Personalized Cell Therapeutic Sales, Revenue, Price and Gross Margin (2020-2025)
13.9.4 GSK Plc Main Business Overview
13.9.5 GSK Plc Latest Developments
13.10 Pfizer Inc
13.10.1 Pfizer Inc Company Information
13.10.2 Pfizer Inc Personalized Cell Therapeutic Product Portfolios and Specifications
13.10.3 Pfizer Inc Personalized Cell Therapeutic Sales, Revenue, Price and Gross Margin (2020-2025)
13.10.4 Pfizer Inc Main Business Overview
13.10.5 Pfizer Inc Latest Developments
13.11 Amneal Pharmaceuticals LLC
13.11.1 Amneal Pharmaceuticals LLC Company Information
13.11.2 Amneal Pharmaceuticals LLC Personalized Cell Therapeutic Product Portfolios and Specifications
13.11.3 Amneal Pharmaceuticals LLC Personalized Cell Therapeutic Sales, Revenue, Price and Gross Margin (2020-2025)
13.11.4 Amneal Pharmaceuticals LLC Main Business Overview
13.11.5 Amneal Pharmaceuticals LLC Latest Developments
13.12 Alvogen
13.12.1 Alvogen Company Information
13.12.2 Alvogen Personalized Cell Therapeutic Product Portfolios and Specifications
13.12.3 Alvogen Personalized Cell Therapeutic Sales, Revenue, Price and Gross Margin (2020-2025)
13.12.4 Alvogen Main Business Overview
13.12.5 Alvogen Latest Developments
13.13 F. Hoffmann-La Roche Ltd
13.13.1 F. Hoffmann-La Roche Ltd Company Information
13.13.2 F. Hoffmann-La Roche Ltd Personalized Cell Therapeutic Product Portfolios and Specifications
13.13.3 F. Hoffmann-La Roche Ltd Personalized Cell Therapeutic Sales, Revenue, Price and Gross Margin (2020-2025)
13.13.4 F. Hoffmann-La Roche Ltd Main Business Overview
13.13.5 F. Hoffmann-La Roche Ltd Latest Developments
13.14 Amgen Inc
13.14.1 Amgen Inc Company Information
13.14.2 Amgen Inc Personalized Cell Therapeutic Product Portfolios and Specifications
13.14.3 Amgen Inc Personalized Cell Therapeutic Sales, Revenue, Price and Gross Margin (2020-2025)
13.14.4 Amgen Inc Main Business Overview
13.14.5 Amgen Inc Latest Developments
13.15 Jazz Pharmaceuticals, Inc
13.15.1 Jazz Pharmaceuticals, Inc Company Information
13.15.2 Jazz Pharmaceuticals, Inc Personalized Cell Therapeutic Product Portfolios and Specifications
13.15.3 Jazz Pharmaceuticals, Inc Personalized Cell Therapeutic Sales, Revenue, Price and Gross Margin (2020-2025)
13.15.4 Jazz Pharmaceuticals, Inc Main Business Overview
13.15.5 Jazz Pharmaceuticals, Inc Latest Developments
13.16 Amicus Therapeutics, Inc
13.16.1 Amicus Therapeutics, Inc Company Information
13.16.2 Amicus Therapeutics, Inc Personalized Cell Therapeutic Product Portfolios and Specifications
13.16.3 Amicus Therapeutics, Inc Personalized Cell Therapeutic Sales, Revenue, Price and Gross Margin (2020-2025)
13.16.4 Amicus Therapeutics, Inc Main Business Overview
13.16.5 Amicus Therapeutics, Inc Latest Developments
13.17 MeiraGTx Limited
13.17.1 MeiraGTx Limited Company Information
13.17.2 MeiraGTx Limited Personalized Cell Therapeutic Product Portfolios and Specifications
13.17.3 MeiraGTx Limited Personalized Cell Therapeutic Sales, Revenue, Price and Gross Margin (2020-2025)
13.17.4 MeiraGTx Limited Main Business Overview
13.17.5 MeiraGTx Limited Latest Developments
13.18 Rocket Pharmaceuticals, Inc
13.18.1 Rocket Pharmaceuticals, Inc Company Information
13.18.2 Rocket Pharmaceuticals, Inc Personalized Cell Therapeutic Product Portfolios and Specifications
13.18.3 Rocket Pharmaceuticals, Inc Personalized Cell Therapeutic Sales, Revenue, Price and Gross Margin (2020-2025)
13.18.4 Rocket Pharmaceuticals, Inc Main Business Overview
13.18.5 Rocket Pharmaceuticals, Inc Latest Developments
13.19 Gilead Sciences, Inc
13.19.1 Gilead Sciences, Inc Company Information
13.19.2 Gilead Sciences, Inc Personalized Cell Therapeutic Product Portfolios and Specifications
13.19.3 Gilead Sciences, Inc Personalized Cell Therapeutic Sales, Revenue, Price and Gross Margin (2020-2025)
13.19.4 Gilead Sciences, Inc Main Business Overview
13.19.5 Gilead Sciences, Inc Latest Developments
14 Research Findings and Conclusion

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂